| Literature DB >> 19492146 |
Gabriele Spohn1, Andre Kleinridders, F Thomas Wunderlich, Matthias Watzka, Frank Zaucke, Katrin Blumbach, Christof Geisen, Erhard Seifried, Clemens Müller, Mats Paulsson, Jens C Brüning, Johannes Oldenburg.
Abstract
Vitamin K hydroquinone is oxidised to the epoxide form (K>O) during vitamin K-dependent posttranslational gamma-glutamyl carboxylation resulting in biological active so called vitamin K-dependent proteins. In turn, K>O is reduced by the enzyme VKORC1 (vitamin K epoxide reductase complex component 1) to complete the vitamin K cycle. To investigate the biological role of VKORC1 in vivo, we generated VKORC1 knockout mice. Homozygous VKORC1-deficient mice developed normally until birth. Within 2-20 days after birth, the knockout mice died due to extensive, predominantly intracerebral haemorrhage. Bleeding resulted from a severe deficiency of gamma-carboxylated clotting factors. This lethal phenotype could be rescued by oral administration of vitamin K. Additionally, morphometric analysis of the limbs in VKORC1-deficient animals revealed reduced length of bone calcification relative to wild-type control mice. The observed phenotype of VKORC1 knockout mice excludes the existence of other enzymes with VKOR activity that can substitute to supply vitamin K hydroquinone required for maturation of blood clotting factors. Thus, our study underscores the essential role of VKORC1 in vitamin K-dependent gamma-glutamyl carboxylation.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19492146
Source DB: PubMed Journal: Thromb Haemost ISSN: 0340-6245 Impact factor: 5.249